Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 12 04:00PM ET
35.49
Dollar change
-0.35
Percentage change
-0.98
%
Index- P/E- EPS (ttm)-1.91 Insider Own0.83% Shs Outstand183.45M Perf Week-14.81%
Market Cap6.51B Forward P/E- EPS next Y-0.38 Insider Trans0.00% Shs Float181.93M Perf Month-11.67%
Income-348.13M PEG- EPS next Q-0.25 Inst Own49.82% Short Float13.09% Perf Quarter-29.46%
Sales520.18M P/S12.52 EPS this Y41.50% Inst Trans-0.59% Short Ratio17.04 Perf Half Y-18.73%
Book/sh6.08 P/B5.83 EPS next Y55.27% ROA-19.47% Short Interest23.81M Perf Year-42.88%
Cash/sh6.61 P/C5.37 EPS next 5Y- ROE-28.35% 52W Range35.52 - 70.13 Perf YTD-41.02%
Dividend Est.- P/FCF- EPS past 5Y-168.48% ROI-23.87% 52W High-49.39% Beta0.09
Dividend TTM- Quick Ratio4.90 Sales past 5Y50.60% Gross Margin58.66% 52W Low-0.08% ATR (14)2.12
Dividend Ex-Date- Current Ratio4.98 EPS Y/Y TTM35.99% Oper. Margin-67.52% RSI (14)29.48 Volatility6.15% 5.26%
Employees1826 Debt/Eq0.31 Sales Y/Y TTM122.96% Profit Margin-66.92% Recom1.23 Target Price80.56
Option/ShortYes / Yes LT Debt/Eq0.31 EPS Q/Q-99.62% Payout- Rel Volume1.02 Prev Close35.84
Sales Surprise11.32% EPS Surprise-3.12% Sales Q/Q66.86% EarningsNov 12 BMO Avg Volume1.40M Price35.49
SMA20-12.23% SMA50-17.57% SMA200-28.10% Trades Volume1,422,904 Change-0.98%
Date Action Analyst Rating Change Price Target Change
Oct-08-24Initiated Redburn Atlantic Buy $86
Jun-17-24Initiated Truist Buy $88
May-24-24Reiterated H.C. Wainwright Buy $86 → $73
May-23-24Initiated Deutsche Bank Buy $60
Apr-17-24Upgrade Scotiabank Sector Perform → Sector Outperform $65
Apr-03-24Initiated Cantor Fitzgerald Overweight $82
Mar-13-24Initiated Raymond James Outperform $86
Dec-19-23Initiated Scotiabank Sector Perform
Nov-06-23Initiated Goldman Buy $90.09
May-25-23Initiated William Blair Mkt Perform $64
Dec-11-24 07:22AM
Dec-09-24 07:35PM
04:22PM
Nov-27-24 10:02AM
Nov-22-24 07:31AM
05:28PM Loading…
Nov-21-24 05:28PM
Nov-13-24 03:28AM
02:07AM
Nov-12-24 09:30AM
07:00AM
Nov-11-24 09:55AM
07:04AM
Nov-07-24 07:30AM
Nov-05-24 09:10AM
Nov-04-24 07:30AM
09:55AM Loading…
Oct-24-24 09:55AM
08:00AM
Oct-16-24 03:45PM
Oct-03-24 07:30AM
Sep-30-24 04:11PM
09:46AM
Sep-27-24 04:35PM
04:30PM
Sep-24-24 09:00AM
Sep-14-24 07:22PM
Sep-12-24 03:34AM
Sep-03-24 12:01PM
Aug-27-24 10:28AM
Aug-20-24 08:00AM
Aug-09-24 07:00AM
04:05PM Loading…
Aug-08-24 04:05PM
Jul-29-24 03:24PM
Jul-26-24 07:00AM
Jul-15-24 09:17AM
07:39AM
Jul-10-24 08:00AM
Jul-02-24 08:00AM
Jun-24-24 08:13AM
Jun-20-24 05:26PM
Jun-03-24 04:00PM
May-29-24 08:00AM
May-23-24 05:00PM
May-15-24 08:19AM
May-14-24 09:23AM
06:54AM
03:01AM
12:20AM
May-13-24 11:53AM
09:24AM
08:57AM
07:30AM
07:00AM
May-09-24 08:52AM
Apr-25-24 11:28AM
Apr-22-24 01:37PM
01:05PM
Apr-11-24 08:00AM
Apr-08-24 08:48AM
Apr-05-24 11:36PM
11:30PM
Apr-03-24 05:39AM
Mar-29-24 05:09AM
Mar-19-24 08:30AM
Mar-17-24 08:50AM
Mar-15-24 03:15PM
Mar-12-24 08:20AM
Mar-11-24 07:00AM
Feb-23-24 07:15AM
Feb-13-24 08:00AM
Feb-07-24 02:41AM
Jan-22-24 08:34PM
08:11PM
08:05AM
Jan-03-24 08:30AM
Jan-02-24 10:29AM
08:30AM
Dec-26-23 06:56PM
Dec-19-23 11:40AM
Dec-11-23 07:30PM
Nov-28-23 02:51PM
Nov-24-23 04:02PM
Nov-20-23 11:09PM
06:00AM
Nov-16-23 05:50AM
Nov-14-23 10:47AM
Nov-13-23 08:30AM
07:00AM
Nov-07-23 08:30AM
Nov-02-23 09:17AM
Oct-30-23 10:39AM
Oct-20-23 05:10AM
Oct-03-23 05:52AM
Sep-21-23 08:00AM
Aug-16-23 02:40AM
Aug-15-23 06:00AM
Aug-14-23 08:36AM
07:15AM
Aug-10-23 08:14AM
Aug-07-23 06:57PM
Aug-03-23 08:30AM
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heyman Tomas J.DirectorDec 02 '24Proposed Sale43.314,366189,080Dec 02 03:08 PM
Huang YingOfficerSep 25 '24Proposed Sale44.101,50466,326Sep 25 03:30 PM
Macomber LoriOfficerSep 20 '24Proposed Sale48.9190,0604,405,003Sep 20 04:43 PM
Yau Wai Man PhilipDirectorSep 20 '24Proposed Sale51.041,94699,324Sep 20 10:46 AM